2 ‘ANNEX I, Decision_act (EU) 2005/413

In forcesince 30 May 2005

[Rapid tests and primary molecular tests.’]

(in EUR)

Disease | Member State | Rate tests performed | Maximum amount

TSEs | Austria | 100 % | 2076000

Belgium | 100 % | 3586000

Cyprus | 100 % | 353000

Czech Republic | 100 % | 1736000

Denmark | 100 % | 2426000

Estonia | 100 % | 294000

Finland | 100 % | 1170000

France | 100 % | 29755000

Germany | 100 % | 15170000

Greece | 100 % | 1487000

Hungary | 100 % | 1184000

Ireland | 100 % | 6172000

Italy | 100 % | 8677000

Lithuania | 100 % | 836000

Luxembourg | 100 % | 155000

Malta | 100 % | 36000

Netherlands | 100 % | 4510000

Portugal | 100 % | 1480000

Slovenia | 100 % | 444000

Spain | 100 % | 8846000

Sweden | 100 % | 313000

United Kingdom | 100 % | 5690000

Total | 96396000